Ideas

October 29, 2017

Published by admin_auro at October 29, 2017

Categories

Natural product therapy for pulmonary arterial hypertension: Tanshinone IIA, one of the main components of Salvia miltiorrhiza, inhibits the development of pulmonary arterial hypertension via down regulation of its target gene Notch3, 29/October/2017, 7.40 am

What they say: A study from the University of California, La Jolla, California, USA shows that “Notch3 signaling promotes the development of pulmonary arterial hypertension.” This study was published, in the 15 November 2009 issue of the journal “Nature Medicine”[the number […]

October 29, 2017

Published by admin_auro at October 29, 2017

Categories

Molecular therapy for inflammation and arthritis: Docosahexaenoic acid (DHA) increases IL-9, increases IL-9 levels, increases proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up regualtion of its target genes, 29/October/2017, 7.10 am

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that […]

October 27, 2017

Published by admin_auro at October 27, 2017

Categories

Molecular therapy for attenuating pathogenesis of Myocardial infarction: Netoglitazone, an anti-diabetic medication, decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 28/October/2017, 1.16 am

Introduction: What they say: A recent study from Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; and Center for Systems […]

October 27, 2017

Published by admin_auro at October 27, 2017

Categories

Cardiac rejuvenation therapy: A therapeutic mix encompassing Rivaroxaban and Asprin (RA) suppresses tumor suppressor INK4a/p16 expression, promotes cardiac repair, delays cardiac ageing and senescence, and extends life span via up regulation of its target gene, 28/October/2017, 12.26 am

Introduction: What they say A recent study from the Population Health Research Institute, McMaster University and Hamilton Health Sciences, David Braley Research Bldg., Hamilton General Hospital, […]